MYBL2 and neoplasm: Overexpression of several proteins that play crucial roles as components or regulators of the MMB complex, including B-Myb (56–59), FoxM1 (60,61) and Plk1 (62), have previously already been shown to correlate with aggressive tumor phenotype and poor prognosis for patients.